Ethan has over 15 years of business and operating experience in mid cap and Fortune 500 companies. He joined Pfizer in 2004 and led the company’s efforts in areas of clinical R&D, business strategy, M&A and licensing due diligence, and alliance management across multi-billion dollar assets. Driven by a passion to help accelerating innovations in the aging, AI/drug discovery and digital health space, he currently advises a number of early stage companies on strategies, partnership and business development, capital raise and investor relations.
Most recently, he serves as a CBO of a senescent modulation platform startup leading business development and other value creation opportunities. Ethan holds a B.S. in biochemistry at Haverford College and a M.B.A. from Columbia Business School.